Vitrolife AB (publ) (STO:VITR)

Market Cap	21.19B
Revenue (ttm)	3.61B
Net Income (ttm)	498.00M
Shares Out	135.42M
EPS (ttm)	3.67
PE Ratio	42.64
Forward PE	35.23
Dividend	1.10 (0.70%)
Ex-Dividend Date	Apr 30, 2025

Volume	49,762
Average Volume	234,649
Open	155.60
Previous Close	156.50
Day's Range	151.00 - 155.90
52-Week Range	142.90 - 268.00
Beta	1.83
RSI	48.22
Earnings Date	Jul 17, 2025

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 1,169
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: VITR